Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online July 19, 2007
Stem Cells Vol. 25 No. 10 October 2007, pp. 2469 -2475
doi:10.1634/stemcells.2007-0049; www.StemCells.com
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2007-0049v1
25/10/2469    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imai, N.
Right arrow Articles by Fujita, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imai, N.
Right arrow Articles by Fujita, T.

TISSUE-SPECIFIC STEM CELLS

Inhibition of Histone Deacetylase Activates Side Population Cells in Kidney and Partially Reverses Chronic Renal Injury

Naohiko Imaia, Keiichi Hishikawaa,b, Takeshi Marumoa,b, Junichi Hirahashia,b, Toshihiko Inowaa,c, Yumi Matsuzakid, Hideyuki Okanod, Tadaichi Kitamurac, David Salante, Toshiro Fujitaa,b

aDepartment of Clinical Renal Regeneration, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan;
bDepartment of Internal Medicine, Division of Nephrology and Endocrinology, University of Tokyo, Bunkyo-ku, Tokyo, Japan;
cDepartment of Urology, University of Tokyo, Bunkyo-ku, Tokyo, Japan;
dDepartment of Physiology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan;
eRenal Section, Evans Biomedical Research Center, Boston University Medical Center, Boston, Massachusetts, USA

Key Words. Stem cell • Side population • Transcription regulation • Chronic renal failure • Anti-glomerular basement membrane disease

Correspondence: Keiichi Hishikawa, M.D., Ph.D., Department of Internal Medicine, Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-865, Japan. Telephone: +81-3-3815-5411, ext. 35725; Fax: +81-3-5800-9738; e-mail: hishikawa-tky{at}umin.ac.jp

Received January 23, 2007; accepted for publication July 9, 2007.
First published online in STEM CELLS EXPRESS   July 19, 2007.



Bone morphogenic protein (BMP)-7 is expressed in the adult kidney and reverses chronic renal injury when given exogenously. Here, we report that a histone deacetylase inhibitor, trichostatin A (TSA), attenuates chronic renal injury, in part, by augmenting the expression of BMP-7 in kidney side population (SP) cells. We induced accelerated nephrotoxic serum nephritis (NTN) in C57BL/6 mice and treated them with TSA for 3 weeks. Compared with vehicle-treated NTN mice, treatment with TSA prevented the progression of proteinuria, glomerulosclerosis, interstitial fibrosis, and loss of kidney SP cells. Basal gene expression of renoprotective factors such as BMP-7, vascular endothelial growth factor, and hepatocyte growth factor was significantly higher in kidney SP cells as compared with non-SP cells. Treatment with TSA significantly upregulated the expression of BMP-7 in SP cells but not in non-SP cells. Moreover, initiation of treatment with TSA after 3 weeks of NTN (for 3 weeks, until 6 weeks) partially but significantly reversed renal dysfunction. Our results indicate an important role of SP cells in the kidney as one of the possible generator cells of BMP-7 and TSA as a stimulator of the cells in reversing chronic renal disease.

Disclosure of potential conflicts of interest is found at the end of this article.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 2007 by AlphaMed Press.